This breakthrough data showed that in myelodysplastic syndrome (MDS) patients with chromosome 5q deletion treatment, Revlimid can provide long-term durable results and help them to remain transfusion free.
The companies intend to develop, and distribute tenofovir to women in resource-limited countries to prevent infection with HIV, the virus that causes AIDS. “It is through public-private partnerships
The trial, which is taking place in Sweden, will assess the efficacy and safety of topical interferon alpha-2b compared with placebo over an examination period of four months
The study met its primary endpoint by demonstrating superior progression free survival in patients with B-cell chronic lymphocytic leukemia (B-CLL) treated with Campath versus chlorambucil. Campath reduced the
The study failed to show that cintredekin besudotox was as effective as current treatment, Gliadel Wafer. The wafer is implanted in the cavity the tumor once occupied after
The restraining order related to alleged infringement of Oxandrin patents held by Savient. Oxandrin is an oral anabolic agent indicated as adjunctive therapy to promote weight gain and
Analysis of data from the study showed that Promacta at 50mg or 75mg resulted in a positive trend in decrease in bleeding incidence in adult patients with chronic
The initial focus of the agreement will be Fentora, which received FDA approval in September 2006, for the management of breakthrough pain in patients with cancer who are
Under the terms of the agreement, Merck will receive rights to a number of Idera's agonist compounds targeting Toll-like Receptor (TLR) 7, 8 and 9 for use in
The results were from a study of high-risk MDS and AML post-MDS patients treated under the French ATU, which provides a temporary authorization for compassionate use of Vidaza
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.